Experts: Trump’s latest drug pricing executive order faces uphill battle

President Donald J. Trump’s executive order that allows HHS to cap certain prescription drug prices for Medicare to what he called the “most-favored-nation price” will be difficult to implement, experts said.The executive order, signed Sept. 13, states that Medicare Part B and Part D drug prices will align with the lowest cost of a drug that is sold to any country in the Organisation for Economic Co-operation and Development that has a “comparable per-capita gross domestic product.”Nancy Nielsen, MD, PhD, a former senior advisor at CMS and now senior associateRead More

Share on facebook
Share on twitter
Share on linkedin